Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-17-010314
Filing Date
2017-04-14
Accepted
2017-04-14 16:05:28
Documents
1
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4536
  Complete submission text file 0000899243-17-010314.txt   6125
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Perkins Adelene Q (Reporting) CIK: 0001375124 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-31141 | Film No.: 17762931